Travel and Acommodation | Registration is complimentary; however, attendees will be responsible for their own travel and accommodations.
prIME Oncology can assist you with your room reservations at the Marriott hotel at a discounted rate. prIME Oncology can not guarantee rooms will be available. Once the booking has been made, the cancellation policy of the hotel will apply. Room cancellation received after 20 October, the full amount of the reserved nights will be charged. No refund will apply. To guarantee the booking, please forward your credit card details to prIME Oncology. Payment of the room should be made directly to the hotel upon checkout.
Standard Single: € 140
Standard Double: € 150
Incl. breakfast and VAT
|
 Faculty |
Untitled Document
Co-Chairs: |
|
Christos Markopoulos, MD
Athens University Medical School
Athens, Greece |
Cornelis van de Velde, MD, PhD
Leiden University
Leiden, The Netherlands |
| |
|
| Moderators: |
|
Lee Lokey, MD
prIME Oncology
Atlanta, Georgia, United States |
Bojana Pajk, MD
prIME Oncology
The Hague, The Netherlands |
| |
|
| Speakers: |
|
Helen Gogas, MD
University of Athens
Athens, Greece |
Fiona MacNeill, MD
Royal Marsden Hospital
London, United Kingdom
|
| |
|
Nadia Harbeck, MD, PhD
University of Cologne
Cologne, Germany |
Giuseppe Viale, MD, PhD
European Institute of Oncology
Milan, Italy |
| |
|
Ian Kunkler, MD
University of Edinburgh
Edinburgh, Scotland |
Harmien Zonderland, MD
Academic Medical Center
Amsterdam, The Netherlands |
| |
|
Spyros Lazarou, MD
Consultant Radiologist
Athens, Greece
|
|
|
 Agenda |
Untitled Document
| Friday, 6 November |
| 16.30 and 18.00 |
Optional Workshop
Ultrasound-guided biopsy to diagnose non-palpable breast lesions
(Preregistration required)
Led by Spyros Lazarou, MD |
| 20.00 |
Welcome reception
|
| |
| Saturday, 7 November 2009 |
| 08.30 |
Welcome, introduction and demographics
Christos Markopoulos, MD
Lee Lokey, MD, or Bojana Pajk, MD |
| |
|
Plenary Session I
Breast Cancer—Diagnosis
Moderator: Fiona MacNeill, MD |
| 08.45 |
Optimal use of breast imaging
Harmien Zonderland, MD |
| 09.10 |
Molecular pathology: A guide for surgeons
Giuseppe Viale, MD, PhD |
|
09.35
|
“Ask the Experts” panel discussion
|
| |
Interactive Clinical Cases (Type A)
Moderator: Christos Markopoulos, MD |
| 09.40 |
Case #1
DCIS: The best approach
Panel Discussion |
| 10.15 |
Break |
| 10.40 |
Case #2
Risk assessment and treatment planning for surgeons
Panel Discussion |
| |
Plenary Session II
Advances in Systemic Therapy
Moderator: Nadia Harbeck, MD, PhD |
| 11.15 |
What surgeons need to know about targeted therapy in breast cancer
Helen Gogas, MD |
| 11.40 |
Advances in adjuvant endocrine therapy for surgeons: Incorporating results of clinical trials into daily clinical practice
Christos Markopoulos, MD |
| 12.05 |
“Ask the Experts” panel discussion |
| 12.15 |
Breast Cancer Opinion Poll |
| 12.45 |
Lunch |
| |
Plenary Session III
Advances in Locoregional Therapy
Moderator: Cornelis van de Velde, MD, PhD |
| 13.45 |
Oncoplastic surgery: Defining its role in breast cancer
Fiona MacNeill, MD |
| 14.10 |
What is new in breast radiotherapy?
Ian Kunkler, MD
|
| 14.35 |
“Ask the Experts” panel discussion |
| |
Interactive Clinical Cases (Type B)
Moderator: Lee Lokey, MD, or Bojana Pajk, MD |
| 14.40 |
Case #3
Multifocal invasive endocrine-responsive breast cancer: locoregional approach and choice of systemic therapy
Nadia Harbeck, MD, PhD |
| 15.15 |
Case #4
Surgical management of large tumors: Neoadjuvant treatment strategies
Cornelis van de Velde, MD, PhD
|
| 15.50 |
Concluding Remarks
Christos Markopoulos, MD
|
|

|
|
|
Program Slides | H.M. Zonderland, MD, PhD- Optimal Use of Breast Imaging
Giuseppe Viale, MD, FRCPath- Molecular Pathology: A Guide for Surgeons
Case#1- DCIS: The Best Approach
Case#2- Risk Assessment and Treatment Planning for Surgeons
Helen Gogas, MD- What Surgeons Need to Know About Targeted Therapy in Breast Cancer
Christos Markopoulos, MD- Advances in Adjuvant Endocrine Therapy for Surgeons
Fiona Mac Neill, MBBS, FRCS, MD- Oncoplastic Surgery: Defining its Role in Breast Cancer Surgery
Ian Kunkler, MD- What is New in Breast Radiotherapy?
Case#3- Multifocal Invasive Endocrine-Responsive Breast Cancer: Locoregional Approach and Choice of Systemic Therapy
Case#4- Surgical Management of Large Tumors: Neoadjuvant Treatment Strategies
|
Support | Support for this activity has been provided by Genomic Health and Novartis Oncology Greece.
|
Organizer | This meeting is a prIME Oncology activity.
|
|